They contain a man-made version of the hormone glucagon-like peptide 1 (GLP-1), which is produced by the intestines and prompts the body to release insulin – the chemical that controls blood sugar levels.
Sucralose, the artificial sweetener of Splenda®, was found to have an effect on the absorption of glucose and subsequent insulin secretion in non-diabetic, obese individuals
Studies found that chlorogenic acid, commonly found in coffee, failed to improve metabolic parameters in obese mice
Working the night shift may reduce glucose tolerance and increase a person’s risk of developing Type 2 diabetes, according to a new study from researchers in Boston.
US government health experts are recommending changes to safety restrictions on former blockbuster diabetes pill Avandia, in light of a new analysis suggesting that the drug may not increase the risk of heart attack as previously believed.
A report published in JAMA Internal Medicine found that vegetarian diets were associated with longer lives – a finding that came from analyzing the diets of more than 70,000 Seventh-day Adventists.
Adopting a Nordic diet can help lower cholesterol and decrease inflammation associated with pre-diabetes, a new study from Lund University reports.
Obesity surgery worked much better at reducing and even reversing diabetes than medication and lifestyle changes in one of the most rigorous studies of its kind. But the researchers and others warn that possible serious complications need to be considered.
Obese teenagers who reduced their body mass index (BMI) by 8 percent or more had improvements in insulin sensitivity, an important metabolic factor related to the later development of type 2 diabetes.
The American Academy of Sleep Medicine (AASM) is advising anyone with Type 2 diabetes or hypertension to be evaluated for sleep apnea by a board-certified sleep medicine physician.
A new study suggests that night work may impair glucose tolerance, supporting a causal role of night work in the increased risk of Type 2 diabetes among shift workers.
Based on his latest study, both the Food and Drug Administration and the European Medicines Agency have begun investigations that could lead to new warnings on the drugs, or even to their removal from the market.
The artificial sweetener may be doing more than making things taste good. New study probes how it effects metabolism and whether raised insulin levels could lead to consumers developing insulin resistance, which may eventually lead to type II diabetes
University of Missouri scientist Habib Zaghouani, PhD, is developing a potential cure for type 1 diabetes by combining adult stem cells with a promising new drug he developed at MU
Aggressive lowering of blood pressure may be associated with increased risk of coronary heart disease (CHD) in black or white patients with diabetes, according to research published online May 20 in Diabetes Care.
While media reports have been quick to label this a breakthrough in the study of treatments for type 2 diabetes, its value to T1D research has yet to be determined.
In their paper published in the journal Nature, the team describes how they compared the faecal metagenome of 145 European women with varying degrees of glucose intolerance against healthy individuals
According to Professor Edwin Gale, applying the term ‘Type 2 diabetes’ to the complex and varied set of symptoms experienced by people with the condition is what logicians call a category error, when a problem is assigned to a category inappropriate to its solution.
According to an analysis of 16 studies, women with diabetes are 23% more likely than other women to develop breast cancer, especially after menopause, and 44% more likely to die of it.
Understanding the ways in which the immune system normally controls and suppresses T cells is crucial to our understanding what goes wrong in autoimmune diseases, and also gives us new tools as we try to treat the incorrectly activated cells we see in type 1 diabetes.